CoChat

Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome

Open access
Mars, Ruben A.T., Yang, Yi, Ward, Tonya, Houtti, Mo, Priya, Sambhawa, Lekatz, Heather R., Tang, Xiaojia, Sun, Zhifu, Kalari, Krishna R., Korem, Tal, Bhattarai, Yogesh, Zheng, Tenghao, Bar, Noam, Frost, Gary, Johnson, Abigail J., van Treuren, Will, Han, Shuo, Ordog, Tamas, Grover, Madhusudan, Sonnenburg, Justin, D’Amato, Mauro, Camilleri, Michael, Elinav, Eran, Segal, Eran, Blekhman, Ran, Farrugia, Gianrico, Swann, Jonathan R., Knights, Dan, Kashyap, Purna C. · 2020 · Cell
Cited by 68

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

SUMMARY The gut microbiome has been implicated in multiple human chronic gastrointestinal (GI) disorders. Deter-mining its mechanistic role in disease has been difficult due to apparent disconnects between animal and human studies and lack of an integrated multi-omics view of disease-specific physiological changes. We integrated longitudinal multi-omics data from the gut microbiome, metabolome, host epigenome, and transcriptome in the context of irritable bowel syndrome (IBS) host physiology. We identified IBS subtype-specific and symptom-related variation in microbial composition and function. A subset of identified changes in microbial metabolites correspond to host physiological mechanisms that are relevant to IBS. By integrating multiple data layers, we identified purine metabolism as a novel host-microbial metabolic pathway in IBS with translational potential. Our study highlights the importance of longitudinal sampling and integrating complementary multi-omics data to identify functional mechanisms that can serve as therapeutic targets in a comprehensive treatment strategy for chronic GI diseases. of IBS patients (6/11 for BA and 4/11 for tryptamine) at the time of flare. These observations highlight that unique microbial and metabolic features may underlie worsening symptoms in different patients. resulted in 773,789 CpG sites for downstream analyses. Potential batch effects were corrected by the Combat method al., al., 2011). Differentially methylated CpG sites were detected using the limma function with Benjamini-Hochberg multiple testing correction. sites between-group differential p value and methylation difference greater than 5% were considered as differentially methylated CpGs (DMCs). these DMCs (differentially methylated (DMRs)) identified correct for differences in gender and small numbers of male samples only biopsy samples from female subjects were included for interpretation. We focused our analysis on samples from the first biopsy time point and used time point 2 samples as a verification cohort. gene-gender

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.10.040

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 68

Metadata

Authors
Mars, R. A. T., Yang, Y., Ward, T., Houtti, M., Priya, S., Lekatz, H. R., Tang, X., Sun, Z., Kalari, K. R., Korem, T., Bhattarai, Y., Zheng, T., Bar, N., Frost, G., Johnson, A. J., van Treuren, W., Han, S., Ordog, T., Grover, M., Sonnenburg, J., D’Amato, M., Camilleri, M., Elinav, E., Segal, E., Blekhman, R., Farrugia, G., Swann, J. R., Knights, D., & Kashyap, P. C.
Venue
Cell
Publisher
Elsevier BV
Published
2020-11
Volume
183
Issue
4
Pages
1137-1140
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3138964605
Cited by
68
References
7
FWCI
7.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.